Christian Sandrock, MD, MPH, FCCP, expands on determining the severity of an acute bacterial skin and skin structure infection, and how to stratify patients based on SIRS criteria, comorbidities and the size of the infection.
Jason Gallagher, PharmD, discusses how omadacycline could potentially replace fluoroquinolone use in the treatment of complicated skin infections and community-acquired pneumonia.
Christian Sandrock, MD, MPH, FCCP, reviews the factors that contribute to a hospital’s system-wide or episode-of-care costs for the treatment of acute bacterial skin and skin structure infections.
